# Ketamine for Relapse Prevention in Recurrent Depressive Disorder

> **NCT02661061** · PHASE1 · TERMINATED · sponsor: **St Patrick's Hospital, Ireland** · enrollment: 9 (actual)

## Conditions studied

- Depression
- Relapse
- Recurrent Depressive Disorder
- Major Depressive Disorder

## Interventions

- **DRUG:** Ketamine
- **DRUG:** Midazolam

## Key facts

- **NCT ID:** NCT02661061
- **Lead sponsor:** St Patrick's Hospital, Ireland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-12
- **Primary completion:** 2018-05-23
- **Final completion:** 2018-05-23
- **Target enrollment:** 9 (ACTUAL)
- **Why stopped:** Inadequate recruitment
- **Last updated:** 2020-01-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02661061

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02661061, "Ketamine for Relapse Prevention in Recurrent Depressive Disorder". Retrieved via AI Analytics 2026-07-25 from https://api.ai-analytics.org/clinical/NCT02661061. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*